MarketBeat featured Danaher, Moderna, and Vertex Pharmaceuticals in its stock screener.

The entities involved

• MarketBeat →

  American personal finance blog

  • Cantor Fitzgerald restated an overweight rating for MoonLake Immunotherapeutics, which trades on Nasdaq, with data provided by MarketBeat.04:27
  • MarketBeat has provided analyst ratings and targets for two large-cap materials companies: Vulcan Materials Company and Heidelberg Materials.03:37
• Danaher Corporation →

  American conglomerate

  • Danaher Corporation filed a transaction disclosure with the SEC.Sun 10:06
  • MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Sun 01:24
• Moderna →

  American biotechnology company

  • Moderna is advancing vaccine trials in the Democratic Republic of the Congo.Wed 19:27
  • Getty Images provided the image source for an article involving Moderna.Mon 10:11
• Vertex Pharmaceuticals →

  American pharmaceutical company

  • Multiple financial firms, including Americana Partners and Summit Global Investments, adjusted their holdings in Vertex Pharmaceuticals on November 4, 2026.Wed 12:13
  • Royal Bank of Canada raised its price objective for Vertex Pharmaceuticals, with Benzinga and MarketBeat reporting related analyst changes.Tue 17:13

Related events

• MarketBeat's stock screener highlighted TNL Mediagene.Sat 19:36
• MarketBeat listed Regeneron Pharmaceuticals, AbbVie, and Moderna as stocks to watch on October 31, 2026.Sat 16:45
• MarketBeat reported analyst recommendations, noting that both MarketBeat and Jefferies Financial Group are mid-cap finance companies.Sat 04:38
• MarketBeat reported an average stock rating for Superior Group of Companies.Sep 17
• BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.Jul 31